These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 12231540)

  • 1. Tumor-infiltrating macrophages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice.
    Zhang F; Lu W; Dong Z
    Clin Cancer Res; 2002 Sep; 8(9):2942-51. PubMed ID: 12231540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated interferon-beta gene therapy suppresses growth and metastasis of human prostate cancer in nude mice.
    Cao G; Su J; Lu W; Zhang F; Zhao G; Marteralli D; Dong Z
    Cancer Gene Ther; 2001 Jul; 8(7):497-505. PubMed ID: 11498771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
    Lee J; Wang A; Hu Q; Lu S; Dong Z
    Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
    Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
    Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta.
    Dong Z; Greene G; Pettaway C; Dinney CP; Eue I; Lu W; Bucana CD; Balbay MD; Bielenberg D; Fidler IJ
    Cancer Res; 1999 Feb; 59(4):872-9. PubMed ID: 10029078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrogation of tumorigenicity and metastasis of murine and human tumor cells by transfection with the murine IFN-beta gene: possible role of nitric oxide.
    Xie K; Bielenberg D; Huang S; Xu L; Salas T; Juang SH; Dong Z; Fidler IJ
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2283-94. PubMed ID: 9815626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible nitric oxide synthase activity is essential for inhibition of prostatic tumor growth by interferon-beta gene therapy.
    Olson MV; Lee J; Zhang F; Wang A; Dong Z
    Cancer Gene Ther; 2006 Jul; 13(7):676-85. PubMed ID: 16470211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
    Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
    Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
    Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of primary murine fibrosarcomas and induction of systemic immunity by adenovirus-mediated interferon beta gene therapy.
    Lu W; Fidler IJ; Dong Z
    Cancer Res; 1999 Oct; 59(20):5202-8. PubMed ID: 10537298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma.
    Wang B; Xiong Q; Shi Q; Le X; Abbruzzese JL; Xie K
    Cancer Res; 2001 Jan; 61(1):71-5. PubMed ID: 11196200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human and mouse IFN-beta gene therapy exhibits different anti-tumor mechanisms in mouse models.
    Qin XQ; Beckham C; Brown JL; Lukashev M; Barsoum J
    Mol Ther; 2001 Oct; 4(4):356-64. PubMed ID: 11592839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of recombinant adenoviral vectors expressing murine IFN-alpha in mice injected with metastatic IFN-resistant tumor cells.
    Santodonato L; Ferrantini M; Palombo F; Aurisicchio L; Delmastro P; La Monica N; Di Marco S; Ciliberto G; Du MX; Taylor MW; Belardelli F
    Cancer Gene Ther; 2001 Jan; 8(1):63-72. PubMed ID: 11219495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
    Ji L; Fang B; Yen N; Fong K; Minna JD; Roth JA
    Cancer Res; 1999 Jul; 59(14):3333-9. PubMed ID: 10416589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity.
    Odaka M; Sterman DH; Wiewrodt R; Zhang Y; Kiefer M; Amin KM; Gao GP; Wilson JM; Barsoum J; Kaiser LR; Albelda SM
    Cancer Res; 2001 Aug; 61(16):6201-12. PubMed ID: 11507073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model.
    Nasu Y; Bangma CH; Hull GW; Lee HM; Hu J; Wang J; McCurdy MA; Shimura S; Yang G; Timme TL; Thompson TC
    Gene Ther; 1999 Mar; 6(3):338-49. PubMed ID: 10435084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice.
    Stearns ME; Garcia FU; Fudge K; Rhim J; Wang M
    Clin Cancer Res; 1999 Mar; 5(3):711-20. PubMed ID: 10100726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice.
    Kim SJ; Uehara H; Karashima T; Shepherd DL; Killion JJ; Fidler IJ
    Clin Cancer Res; 2003 Mar; 9(3):1200-10. PubMed ID: 12631626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.